Furthermore, it has been demonstrated that thalidomide inhibits the production of inflammatory cytokines, including TNF-α, TGF-β1 and nuclear factor-κB (NF-κB), thereby reducing the degree of pulmonary fibrosis. Here, NFKB1 is linked to pulmonary fibrosis.